Based on the available information, there is no explicit statement regarding the administration of live vaccines during Cosentyx (secukinumab) treatment.

Cosentyx is a biologic medication used to treat various conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. The drug's official website, Cosentyx.com, provides information on various topics related to the medication, including its use during the COVID-19 pandemic [2]. However, it does not specifically address the question of live vaccine administration during Cosentyx treatment.

A study published in the Journal of Dermatological Treatment discusses the safety and immunogenicity of vaccines in patients receiving biologic therapy for psoriasis [3]. The study mentions that live vaccines should be administered prior to starting biologic therapy or after discontinuing such treatment. However, it does not specifically mention Cosentyx by name.

In summary, while there is no specific information on the administration of live vaccines during Cosentyx treatment, it is generally recommended to administer live vaccines before starting biologic therapy or after discontinuing such treatment [3]. As with any medical decision, it is essential to consult with a healthcare provider for personalized advice.

Sources:
[1] <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
[2] <https://www.cosentyx.com/all/covid19>
[3] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>